Plassche Douglas 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Plassche Douglas
EVP Operations
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2026-01-09$0.03/sh+2,500,000$75,000→ 6,000,000 total - Exercise/Conversion
Stock Options (right to buy)
[F1]2026-01-09−2,500,000→ 0 totalExercise: $0.03From: 2026-01-03Exp: 2033-01-03→ Common Stock (2,500,000 underlying)
Footnotes (1)
- [F1]All of the stock options were fully vested and exercisable as of the transaction date.
Signature
/s/ Douglas Plassche|2026-01-13